Gelonghui, April 24 | According to the latest equity disclosure data of the Stock Exchange, on April 23, 2024, China Biopharmaceutical (01177.HK) was granted an increase of 2 million shares at an average price of HK$2.5891 per share on the market, involving approximately HK$5.1782 million.

After the increase in holdings, Xie Qirun's latest shareholding was 6 million shares, and the shareholding ratio increased from 0.02% to 0.03%.